The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Eli Lilly & Co (NYSE:LLY), Adobe (NASDAQ:ADBE), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Texas Instruments (NASDAQ:TXN), Micron Technology (NASDAQ:MU), KLA Corp (NASDAQ:KLAC), FedEx Corp (NYSE:FDX), Biogen (NASDAQ:BIIB).
The investment seeks long-term capital appreciation.
The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks.
The average market capitalization across the Vanguard PRIMECAP Inv MF is 487.45B. The market cap for tickers in the group ranges from 33.15B to 2.84T. MSFT holds the highest valuation in this group at 2.84T. The lowest valued company is BIIB at 33.15B.
The average weekly volume growth across all stocks in the Vanguard PRIMECAP Inv MF was -6%. For the same stocks of the MF, the average monthly volume growth was 3% and the average quarterly volume growth was -11%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 59
P/E Growth Rating: 38
Price Growth Rating: 36
SMR Rating: 41
Profit Risk Rating: 41
Seasonality Score: 15 (-100 ... +100)